We investigate whether increased racial diversity of clinical trial principal investigators could increase the enrollment of Black patients…
Eligibility criteria for interventions can induce an Ashenfelter Dip, and subsequent mean-reversion may result in improvement over time…
A Discussion with Christine Mitchell, Carlos Martinez, David Fathi, and Shamsher SamraDecember 11, 2024In this final session of the series…
Disparities between Black and White Americans in health care coverage and health outcomes are pervasive in the United States. In this paper…
A Discussion with Sanjay Kishore, Margaret Hayden, Mary Bassett, and John CardNovember 20, 2024In this session we were joined by experts…
A Discussion with Lauren Brinkley-Rubinstein, Keri Blakinger, Ingrid Binswanger, and Craig WaleedOctober 23, 2024The carceral healthcare…
The next U.S. president will inherit multiple epidemics with inequitably distributed effects. Kamala Harris and Donald Trump are likely to…
Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to…
A Discussion with Eunice Cho, Marc Stern, and Esmaeil PorsaOctober 9, 2024In the third session of the Diagnosis of Incarceration speaker…
A Discussion with William Weber, David Himmelstein, and Erick EitingSeptember 25, 2024The second session of the Diagnosis of Incarceration…